Cargando…

The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma

Receptor tyrosine kinases (RTKs) and Yes‐associated protein (YAP) are critical driving factors in tumors. Currently, the regulation of RTKs in the Hippo‐YAP pathway has been recognized as an important issue. However, the relationship between AXL, one of the RTKs, and YAP in head and neck squamous ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiayi, Shi, Chaoji, Zhou, Rong, Han, Yong, Xu, Shengming, Ma, Hailong, Zhang, Zhiyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469783/ https://www.ncbi.nlm.nih.gov/pubmed/32589311 http://dx.doi.org/10.1111/cas.14546

Ejemplares similares

Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma
por: Ma, Hailong, et al.
Publicado: (2018)

Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression
por: von Mässenhausen, Anne, et al.
Publicado: (2016)

The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway
por: Xu, Qiaoshi, et al.
Publicado: (2020)

The potential role of YAP in head and neck squamous cell carcinoma
por: Shin, Eunbie, et al.
Publicado: (2020)

Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma
por: Gu, Ziyue, et al.
Publicado: (2022)

p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma
por: Jin, Shufang, et al.
Publicado: (2019)

Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
por: Santos-de-Frutos, Karla, et al.
Publicado: (2019)

Clinical significance of YAP1 activation in head and neck squamous cell carcinoma
por: Eun, Young-Gyu, et al.
Publicado: (2017)

Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3
por: Thilakasiri, Pathum, et al.
Publicado: (2023)

Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma
por: Liu, Shuli, et al.
Publicado: (2017)

TGFβ promotes YAP‐dependent AXL induction in mesenchymal‐type lung cancer cells
por: Choi, Jeong‐Yun, et al.
Publicado: (2020)

YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
por: Ghiso, Elena, et al.
Publicado: (2017)

AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer
por: Iida, Mari, et al.
Publicado: (2022)

The Role of lncRNA Crosstalk in Leading Cancer Metastasis of Head and Neck Squamous Cell Carcinoma
por: Wang, Yu, et al.
Publicado: (2020)

Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma
por: Fan, Teng-Fei, et al.
Publicado: (2016)

EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy
por: Liu, Shuli, et al.
Publicado: (2020)

Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2016)

Targeting LSD1 suppresses stem cell-like properties and sensitizes head and neck squamous cell carcinoma to PD-1 blockade
por: Han, Yong, et al.
Publicado: (2021)

Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma
por: Burgy, Mickaël, et al.
Publicado: (2021)

LncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neck
por: Yu, Changyun, et al.
Publicado: (2018)

YTHDC1 Promotes Stemness Maintenance and Malignant Progression in Head and Neck Squamous Cell Carcinoma
por: Weng, Junquan, et al.
Publicado: (2022)

Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck Cancer
por: Busch, Chia-Jung, et al.
Publicado: (2022)

Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma
por: Lamhamedi-Cherradi, Salah-Eddine, et al.
Publicado: (2021)

Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2019)

Mining database for the expression and clinical significance of STAT family in head and neck squamous cell carcinomas
por: Ni, Haosheng, et al.
Publicado: (2020)

Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1
por: Liu, Kui, et al.
Publicado: (2019)

The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma
por: Jin, Shufang, et al.
Publicado: (2022)

A Dysbiotic Microbiome Promotes Head and Neck Squamous Cell Carcinoma
por: Frank, Daniel N., et al.
Publicado: (2022)

UBE2O Promotes Progression and Epithelial–Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Chen, Xiyu, et al.
Publicado: (2020)

Caveolin‐1 promotes cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma
por: Lu, Tingwei, et al.
Publicado: (2021)

Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma
por: Hagege, Anais, et al.
Publicado: (2022)

Integrin β3 Promotes Resistance to EGFR-TKI in Non-Small-Cell Lung Cancer by Upregulating AXL through the YAP Pathway
por: Sun, Qi, et al.
Publicado: (2022)

Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma
por: Sanati, Nasim, et al.
Publicado: (2018)

Interleukin-6 role in head and neck squamous cell carcinoma progression
por: Choudhary, Moaz M., et al.
Publicado: (2016)

Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma
por: Ma, Hailong, et al.
Publicado: (2018)

The Crosstalk Between Hippo-YAP Pathway and Innate Immunity
por: Wang, Shuai, et al.
Publicado: (2020)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2019)

OTUB2 Regulates YAP1/TAZ to Promotes the Progression of Esophageal Squamous Cell Carcinoma
por: Liu, Li, et al.
Publicado: (2022)

AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling
por: Fu, Lin, et al.
Publicado: (2021)

YAP drives cutaneous squamous cell carcinoma formation and progression
por: Vincent-Mistiaen, Zoé, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a1r04c3jo84nc6b85o7510um4p